Skip to main content
Clinical Trials/NCT01914874
NCT01914874
Completed
N/A

Efficacy of an Enhanced Mindfulness-based Intervention for Social Anxiety Disorder: A Pilot Feasibility Randomized Controlled Trial

Hopital Montfort1 site in 1 country39 target enrollmentJuly 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Social Anxiety Disorder
Sponsor
Hopital Montfort
Enrollment
39
Locations
1
Primary Endpoint
Social Phobia Inventory
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this study is to evaluate the feasibility and initial efficacy of an enhanced mindfulness-based program that includes "mindful exposure" to reduce anxiety and avoidance of social situations, and the Buddhist practice of self-compassion aimed at reducing harsh judgment and self-criticism that is characteristic of people with social anxiety disorder.

Detailed Description

The purpose of this pilot study is to evaluate the feasibility and initial efficacy of an enhanced mindfulness-based intervention for SAD (MIND-SAD) that incorporates the following components: training in classical mindfulness, including concentration and insight (vipassana) meditation; training in self-compassion; and mindful exposure. An exploratory aim of the study is to evaluate the effects of the mindfulness intervention on biological markers of stress reactivity, including salivary cortisoland salivary alpha-amylase. The study is a two-arm, parallel design, prospective study comparing 12 weekly sessions of MIND-SAD delivered in a group format versus a wait-list control (WLC).

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
January 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Diana Koszycki

Research Chair In Mental Health/Senior Scientist

Hopital Montfort

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of Social Anxiety Disorder; Baseline score of 30 or higher on the Liebowitz Social Anxiety Scale; Baseline score of 4 or higher on the Clinical Global Impression of Severity

Exclusion Criteria

  • Lifetime history of psychosis or bipolar disorder; substance abuse in the past 12 months; diagnosis of borderline or antisocial personality disorder; serious suicide risk; currently in psychotherapy; regular meditation or yoga practice in the past 12 months

Outcomes

Primary Outcomes

Social Phobia Inventory

Time Frame: change from baseline at weeks 6, 12 and 3 months follow-up

Clinician-rated Liebowitz Social Phobia Scale

Time Frame: change from baseline at weeks 6, 12 and 3 months follow-up

Secondary Outcomes

  • CGI-Severity of Illness(change from baseline at weeks 6, 12 and 3 months follow-up)
  • Self-Compassion Scale(change from baseline at weeks 6, 12 and 3-months follow-up)
  • Beck Depression Inventory(change from baseline at weeks 6, 12 and 3 months follow-up)
  • Social Adjustment Scale-Self-Report(change from baseline at weeks 6 and 12 and 3 months follow-up)
  • Five Facet Mindfulness Questionnaire(change from baseline at weeks 6, 12 and 3 months follow-up)

Study Sites (1)

Loading locations...

Similar Trials